Current Research Information SysTem In Norway
 
 

 English version


 
Hovedside
Forskningsresultater/NVI
Forskere
Prosjekter
Forskningsenheter
Logg inn
Om Cristin
 
 
   
Eksporter til


Viser treff 1-4 av 4

2019
1 Holmøy, Trygve; Fevang, Børre; Olsen, David Benee; Spigset, Olav; Bø, Lars.
Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis. BMC Research Notes 2019 ;Volum 12.(1) s. 1-5
UiO AHUS OUS NTNU STO UiB HAUKELAND Untitled
 
2 Myhr, Kjell-Morten; Torkildsen, Øivind; Lossius, Peter Andreas Vold; Bø, Lars; Holmøy, Trygve.
B cell depletion in the treatment of multiple sclerosis. Expert Opinion on Biological Therapy 2019 ;Volum 19.(3) s. 261-271
UiB HAUKELAND UiO OUS AHUS Untitled
 
3 Nystad, Agnes Elisabeth; Lereim, Ragnhild Reehorst; Wergeland, Stig; Oveland, Eystein; Myhr, Kjell-Morten; Bø, Lars; Torkildsen, Øivind.
Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model. Journal of Neuroimmunology 2019 ;Volum 339.
HAUKELAND UiB Untitled
 
4 Stokke, Silje Agnethe; Lehmann, Anne Kristine; Trovik, Linn; Kristoffersen, Einar Klæboe; Bø, Lars; Myhr, Kjell-Morten; Torkildsen, Øivind.
Safety and efficacy of autologous hematopoietic stem cell transplantation for multiple sclerosis in Norway. Multiple Sclerosis 2019 s. 1-9
UiB HAUKELAND Untitled